The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125383771 12538377 1 I 201603 20160629 20160707 20160707 EXP US-JAZZ-2016-US-012221 JAZZ 55.21 YR F Y 0.00000 20160707 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125383771 12538377 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
125383771 12538377 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS U 21196 ORAL SOLUTION
125383771 12538377 3 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, FIRST DOSE U 21196 3.75 G ORAL SOLUTION
125383771 12538377 4 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, SECOND DOSE U 21196 4.5 G ORAL SOLUTION
125383771 12538377 5 SS AMBIEN ZOLPIDEM TARTRATE 1 UNK U 0 TABLET
125383771 12538377 6 C MODAFINIL. MODAFINIL 1 UNK U 0 TABLET
125383771 12538377 7 C SERTRALINE HCL SERTRALINE HYDROCHLORIDE 1 UNK U 0 TABLET
125383771 12538377 8 C Atorvastatin ATORVASTATIN 1 U 0 TABLET
125383771 12538377 9 C BELSOMRA SUVOREXANT 1 U 0 TABLET
125383771 12538377 10 C GLIPIZIDE. GLIPIZIDE 1 U 0 TABLET
125383771 12538377 11 C Metformin Hcl METFORMIN HYDROCHLORIDE 1 U 0 TABLET
125383771 12538377 12 C SILENOR DOXEPIN HYDROCHLORIDE 1 U 0 TABLET
125383771 12538377 13 C TRIAMTERENE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDETRIAMTERENE 1 U 0 TABLET
125383771 12538377 14 C TYLENOL EXTRA STRENGTH ACETAMINOPHEN 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125383771 12538377 1 Narcolepsy
125383771 12538377 5 Product used for unknown indication
125383771 12538377 6 Product used for unknown indication
125383771 12538377 7 Product used for unknown indication
125383771 12538377 8 Product used for unknown indication
125383771 12538377 9 Product used for unknown indication
125383771 12538377 10 Product used for unknown indication
125383771 12538377 11 Product used for unknown indication
125383771 12538377 12 Product used for unknown indication
125383771 12538377 13 Product used for unknown indication
125383771 12538377 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125383771 12538377 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125383771 12538377 Drug ineffective
125383771 12538377 Feeling abnormal
125383771 12538377 Hypertension
125383771 12538377 Insomnia
125383771 12538377 Type 2 diabetes mellitus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125383771 12538377 1 201302 201302 0
125383771 12538377 2 201302 201304 0
125383771 12538377 3 201304 0
125383771 12538377 4 201304 0
125383771 12538377 6 20120601 0
125383771 12538377 7 20100101 0